Your browser doesn't support javascript.
loading
Bisphosphonate-related osteonecrosis of the jaw: specificities.
Paulo, Siri; Abrantes, Ana Margarida; Laranjo, Mafalda; Carvalho, Lina; Serra, Arménio; Botelho, Maria Filomena; Ferreira, Manuel Marques.
Afiliación
  • Paulo S; Faculty of Medicine, Coimbra University , Portugal.
  • Abrantes AM; Faculty of Medicine, Coimbra University , Portugal.
  • Laranjo M; Faculty of Medicine, Coimbra University , Portugal.
  • Carvalho L; Faculty of Medicine, Coimbra University , Portugal.
  • Serra A; Faculty of Science and Technology, Coimbra University , Portugal.
  • Botelho MF; Faculty of Medicine, Coimbra University , Portugal.
  • Ferreira MM; Faculty of Medicine, Coimbra University , Portugal.
Oncol Rev ; 8(2): 254, 2014 Sep 23.
Article en En | MEDLINE | ID: mdl-25992241
ABSTRACT
Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a severe complication that has recently emerged in patients treated with intravenous bisphosphonates for malignant diseases. This complication usually presents after a minor local trauma during a dental treatment. Several etiopathogenic mechanisms of this pathological condition have been proposed, but no model can explain all morphological changes observed at the macroscopic and microscopic level. BRONJ is likely to be related to direct toxicity in the bone and soft tissue cells, due to nitrogen-containing bisphosphonates. This review elucidates the clinical indications and mechanism of action of bisphosphonates, reports some clinical diagnostic criteria for BRONJ, describe the histopathological criteria for BRONJ diagnosis, the potential triggering pathways and the available treatment strategies.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncol Rev Año: 2014 Tipo del documento: Article País de afiliación: Portugal

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncol Rev Año: 2014 Tipo del documento: Article País de afiliación: Portugal